Berkowitz BA - Search Results

1

Critical role of inducible nitric oxide synthase in degeneration of retinal capillaries in mice with streptozotocin-induced diabetes.

Zheng L, Du Y, Miller C, Gubitosi-Klug RA, Kern TS, Ball S, Berkowitz BA. Zheng L, et al. Among authors: berkowitz ba. Diabetologia. 2007 Sep;50(9):1987-1996. doi: 10.1007/s00125-007-0734-9. Epub 2007 Jun 22. Diabetologia. 2007. PMID: 17583794

2

Subnormal retinal oxygenation response precedes diabetic-like retinopathy.

Berkowitz BA, Kowluru RA, Frank RN, Kern TS, Hohman TC, Prakash M. Berkowitz BA, et al. Invest Ophthalmol Vis Sci. 1999 Aug;40(9):2100-5. Invest Ophthalmol Vis Sci. 1999. PMID: 10440266

3

Correction of early subnormal superior hemiretinal DeltaPO(2) predicts therapeutic efficacy in experimental diabetic retinopathy.

Berkowitz BA, Ito Y, Kern TS, McDonald C, Hawkins R. Berkowitz BA, et al. Invest Ophthalmol Vis Sci. 2001 Nov;42(12):2964-9. Invest Ophthalmol Vis Sci. 2001. PMID: 11687543

4

Regulation of the early subnormal retinal oxygenation response in experimental diabetes by inducible nitric oxide synthase.

Berkowitz BA, Luan H, Gupta RR, Pacheco D, Seidner A, Roberts R, Liggett J, Knoerzer DL, Connor JR, Du Y, Kern TS, Ito Y. Berkowitz BA, et al. Diabetes. 2004 Jan;53(1):173-8. doi: 10.2337/diabetes.53.1.173. Diabetes. 2004. PMID: 14693712

5

Effect of PKCbeta on retinal oxygenation response in experimental diabetes.

Luan H, Leitges M, Gupta RR, Pacheco D, Seidner A, Liggett J, Ito Y, Kowluru R, Berkowitz BA. Luan H, et al. Among authors: berkowitz ba. Invest Ophthalmol Vis Sci. 2004 Mar;45(3):937-42. doi: 10.1167/iovs.03-1007. Invest Ophthalmol Vis Sci. 2004. PMID: 14985314

6

Drug intervention can correct subnormal retinal oxygenation response in experimental diabetic retinopathy.

Berkowitz BA, Roberts R, Luan H, Peysakhov J, Knoerzer DL, Connor JR, Hohman TC. Berkowitz BA, et al. Invest Ophthalmol Vis Sci. 2005 Aug;46(8):2954-60. doi: 10.1167/iovs.05-0132. Invest Ophthalmol Vis Sci. 2005. PMID: 16043871

7

Retinal thickness and subnormal retinal oxygenation response in experimental diabetic retinopathy.

Luan H, Roberts R, Sniegowski M, Goebel DJ, Berkowitz BA. Luan H, et al. Among authors: berkowitz ba. Invest Ophthalmol Vis Sci. 2006 Jan;47(1):320-8. doi: 10.1167/iovs.05-0272. Invest Ophthalmol Vis Sci. 2006. PMID: 16384980

8

Blocking ET-1 receptors does not correct subnormal retinal oxygenation response in experimental diabetic retinopathy.

Roberts R, Luan H, Berkowitz BA. Roberts R, et al. Among authors: berkowitz ba. Invest Ophthalmol Vis Sci. 2006 Aug;47(8):3550-5. doi: 10.1167/iovs.05-1624. Invest Ophthalmol Vis Sci. 2006. PMID: 16877428

9

Impaired apparent ion demand in experimental diabetic retinopathy: correction by lipoic Acid.

Berkowitz BA, Roberts R, Stemmler A, Luan H, Gradianu M. Berkowitz BA, et al. Invest Ophthalmol Vis Sci. 2007 Oct;48(10):4753-8. doi: 10.1167/iovs.07-0433. Invest Ophthalmol Vis Sci. 2007. PMID: 17898301

10

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) meeting summary: Advances toward measuring diabetic retinopathy and neuropathy: from the bench to the clinic and back again (April 4-5, 2007, Baltimore, Maryland).

Kern TS, Berkowitz BA, Feldman EL. Kern TS, et al. Among authors: berkowitz ba. J Diabetes Complications. 2009 May-Jun;23(3):219-23. doi: 10.1016/j.jdiacomp.2007.11.001. Epub 2008 Apr 16. J Diabetes Complications. 2009. PMID: 18413183

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

230 results

Search Page

Filters